BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 19, 2009
View Archived Issues
Studies reveal contraceptive efficacy of estradiol valerate/dienogest
Read More
KDR-4, a VEGFR2 inhibitor, developed for local intravitreal delivery
Read More
Avila Therapeutics presents on Btk inhibitor AVL-291, pan-ErbB inhibitor CNX-222 at AACR
Read More
Intellikine describes dual mTORC1/2 inhibitor INK-128
Read More
Data from first-in-human trial of MK-0752 reported
Read More
DNA alkylating agent BO-1062 selected for further development
Read More
GlobeImmune and Celgene collaborate on targeted immunotherapy for cancer
Read More
COTI-2 plus Taxol superior to Taxol alone in animal cancer model
Read More
ERYtech initiates recruitment for phase II clinical trial of Graspa for ALL
Read More
Galapagos reports on activities during first quarter of 2009
Read More
SkyePharma presents report on activities during first quarter of 2009
Read More
Finland approves Ark's Cerepro for treatment on named-patient basis
Read More
Cadence submits NDA to FDA for Acetavance for acute pain and fever in adults and children
Read More
Regulus achieves initial milestone under microRNA collaboration with GSK
Read More
ThromboGenics presents update on activities
Read More
GE Healthcare describes novel agents for X-ray diagnosis
Read More
Suven Life Sciences claims novel 5-HT6 receptor ligands as anxiolytics
Read More
Merck & Co. presents novel JAK and PDK1 kinase inhibitors for cancer treatment
Read More
Novel cathepsin inhibitor VBY-129 developed by Virobay for the treatment of autoimmune diseases
Read More
Ark Therapeutics provides interim pipeline update
Read More
Can-Fite reports positive results from its phase II keratoconjunctivitis sicca trial
Read More
Peplin presents results for phase III PEP-005 trial in actinic keratosis
Read More
Phase IIb DCCR trial for hypertriglyceridemia meets endpoint
Read More
FDA releases clinical hold from Nile's CD-NP Program for heart failure
Read More
Sepracor withdraws marketing authorization application for Lunivia (eszopiclone)
Read More